Radiomic mapping model for prediction of Ki-67 expression in adrenocortical carcinoma

被引:34
作者
Ahmed, A. A. [1 ]
Elmohr, M. M. [2 ]
Fuentes, D. [2 ]
Habra, M. A. [3 ]
Fisher, S. B. [4 ]
Perrier, N. D. [4 ]
Zhang, M. [5 ]
Elsayes, K. M. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
TUMOR HETEROGENEITY; EUROPEAN NETWORK; CANCER; SURVIVAL; INDEX; KI67;
D O I
10.1016/j.crad.2020.01.012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
100231 [临床病理学]; 100902 [航空航天医学];
摘要
AIM: To determine the value of contrast-enhanced computed tomography (CT)-derived radiomic features in the preoperative prediction of Ki-67 expression in adrenocortical carcinoma (ACC) and to detect significant associations between radiomic features and Ki-67 expression in ACC. MATERIALS AND METHODS: For this retrospective analysis, patients with histopathologically proven ACC were reviewed. Radiomic features were extracted for all patients from the preoperative contrast-enhanced abdominal CT images. Statistical analysis identified the radiomic features predicting the Ki-67 index in ACC and analysed the correlation with the Ki-67 index. RESULTS: Fifty-three cases of ACC that met eligibility criteria were identified and analysed. Of the radiomic features analysed, 10 showed statistically significant differences between the high and low Ki-67 expression subgroups. Multivariate linear regression analysis yielded a predictive model showing a significant association between radiomic signature and Ki-67 expression status in ACC (R-2 =0.67, adjusted R-2 =0.462, p=0.002). Further analysis of the independent predictors showed statistically significant correlation between Ki-67 expression and shape flatness, elongation, and grey-level long run emphasis (p=0.002, 0.01, and 0.04, respectively). The area under the curve for identification of high Ki-67 expression status was 0.78 for shape flatness and 0.7 for shape elongation. CONCLUSION: Radiomic features derived from preoperative contrast-enhanced CT images show encouraging results in the prediction of the Ki-67 index in patients with ACC. Morphological features, such as shape flatness and elongation, were superior to other radiomic features in the detection of high Ki-67 expression. (C) 2020 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.
引用
收藏
页码:479.e17 / 479.e22
页数:6
相关论文
共 32 条
[1]
Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review [J].
Alic, Lejla ;
Niessen, Wiro J. ;
Veenland, Jifke F. .
PLOS ONE, 2014, 9 (10)
[2]
[Anonymous], 2017, Cancer Staging Manual
[3]
[Anonymous], IBM SPSS Statistics for windows-version 20.0
[4]
Major Prognostic Role of Ki67 in Localized Adrenocortical Carcinoma After Complete Resection [J].
Beuschlein, Felix ;
Weigel, Jens ;
Saeger, Wolfgang ;
Kroiss, Matthias ;
Wild, Vanessa ;
Daffara, Fulvia ;
Libe, Rosella ;
Ardito, Arianna ;
Al Ghuzlan, Abir ;
Quinkler, Marcus ;
Osswald, Andrea ;
Ronchi, Cristina L. ;
de Krijger, Ronald ;
Feelders, Richard A. ;
Waldmann, Jens ;
Willenberg, Holger S. ;
Deutschbein, Timo ;
Stell, Anthony ;
Reincke, Martin ;
Papotti, Mauro ;
Baudin, Eric ;
Tissier, Frederique ;
Haak, Harm R. ;
Loli, Paola ;
Terzolo, Massimo ;
Allolio, Bruno ;
Mueller, Hans-Helge ;
Fassnacht, Martin .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (03) :841-849
[5]
Intratumoral Heterogeneity for Ki-67 Index in Invasive Breast Carcinoma: A Study on 131 Consecutive Cases [J].
Boros, Monica ;
Moncea, Denisa ;
Moldovan, Cosmin ;
Podoleanu, Cristian ;
Georgescu, Rares ;
Stolnicu, Simona .
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2017, 25 (05) :338-340
[6]
A New Challenge for Radiologists: Radiomics in Breast Cancer [J].
Crivelli, Paola ;
Ledda, Roberta Eufrasia ;
Parascandolo, Nicola ;
Fara, Alberto ;
Soro, Daniela ;
Conti, Maurizio .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[7]
Assessment of tumor heterogeneity: An emerging imaging tool for clinical practice? [J].
Davnall F. ;
Yip C.S.P. ;
Ljungqvist G. ;
Selmi M. ;
Ng F. ;
Sanghera B. ;
Ganeshan B. ;
Miles K.A. ;
Cook G.J. ;
Goh V. .
Insights into Imaging, 2012, 3 (6) :573-589
[8]
Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group [J].
Dickson, Paxton V. ;
Kim, Lawrence ;
Yen, Tina W. F. ;
Yang, Anthony ;
Grubbs, Elizabeth G. ;
Patel, Dhavel ;
Solorzano, Carmen C. .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (12) :3453-3459
[9]
Mcm2, Geminin, and Ki67 define proliferative state and are prognostic markers in renal cell carcinoma [J].
Dudderidge, TJ ;
Stoeber, K ;
Loddo, M ;
Atkinson, G ;
Fanshawe, T ;
Griffiths, DF ;
Williams, GH .
CLINICAL CANCER RESEARCH, 2005, 11 (07) :2510-2517
[10]
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors [J].
Fassnacht, Martin ;
Dekkers, Olaf M. ;
Else, Tobias ;
Gaudin, Eric ;
Berruti, Alfredo ;
de Krijger, Ronald R. ;
Haak, Harm R. ;
Mihail, Radu ;
Assie, Guillaume ;
Terzolo, Massimo .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 179 (04) :G1-G46